Laser in treatment of symptomatic BPH))Benign Prostatic Hyperplasia

Benign prostatic hyperplasia (BPH) is a highly frequent disease in ageing men and associated with benign prostatic enlargement (BPE), lower urinary tract symptoms (LUTS), and benign prostatic obstruction (BPO). Open or transurethral removal of prostatic tissue is the mainstay for the treatment of BPO and BPE. Although transurethral resection of the prostate (TURP) is still considered as the gold standard of surgical treatment significant peri operative morbidity and late complications are associated with the procedure. For example, intra operative bleeding requiring blood transfusion (2.4%), Post-TUR syndrome due to fluid absorption (2.1%), immediate postoperative haematuria & clot retention (3.7%), stricture urethra (2.5%), bladder neck contracture (2.7%), retrograde ejaculation (>60%) and erectile dysfunction (4-13%), are all well documented in urologic literature.